Lorazepam (Ativan) Intramuscular Administration
For intramuscular administration, lorazepam should be dosed at 0.05-0.10 mg/kg (maximum 4 mg per dose) and can be repeated every 10-15 minutes as needed, with injection into the deltoid muscle providing the most rapid and reliable absorption. 1
Dosing Guidelines
Standard IM Dosing
- Adult dose: 0.05-0.10 mg/kg per dose (maximum 4 mg) 1
- Pediatric dose: 0.05-0.10 mg/kg (maximum 4 mg per dose) 1
- Elderly/debilitated patients: Reduce dose to 0.25-0.5 mg (maximum 2 mg in 24 hours) 2
- Frequency: May repeat every 10-15 minutes if needed 1
Specific Clinical Contexts
For status epilepticus: 0.05-0.10 mg/kg IV/IM (maximum 4 mg per dose), repeatable every 10-15 minutes 1. Note that IV route is strongly preferred over IM for seizures due to faster onset.
For anxiety/agitation in adults: 0.5-1 mg orally four times daily as needed is preferred when patient can swallow 2. When unable to swallow, consider subcutaneous midazolam 2.5-5 mg instead, as it has more predictable absorption than IM lorazepam 2.
For sedation/anxiolysis in pediatrics: 0.05-0.10 mg/kg IV given over 2-3 minutes (maximum 5 mg) 1. IM route is acceptable but less preferred.
Injection Site Selection
The deltoid muscle is the preferred injection site based on pharmacokinetic data showing rapid absorption with peak concentrations within 3 hours 3. The study demonstrating this used deltoid injection specifically and showed mean absorption half-life of 21.2 minutes.
Pharmacokinetics of IM Administration
- Onset: Peak plasma concentrations occur within 3 hours 3
- Absorption half-life: Approximately 21 minutes 3
- Elimination half-life: 13.6 hours 3
- Duration of effect: Prolonged anticonvulsant activity compared to diazepam (15-20 minutes) 1
Critical Safety Precautions
Respiratory Monitoring
Monitor oxygen saturation and be prepared to provide respiratory support 1. There is increased risk of apnea when:
- Combined with other sedative agents 1
- Given rapidly IV (less concern with IM) 1
- Used in elderly or debilitated patients 2
Contraindications and High-Risk Situations
Do NOT use flumazenil reversal in most emergency situations as it counteracts anticonvulsant effects and may precipitate seizures 1. Flumazenil is only appropriate for pure benzodiazepine overdose in select low-risk patients 4.
Specific Warnings
- Sedation persists for at least 4 hours even with IM administration 5
- Pain at injection site is common with IM lorazepam and may cause restlessness for 20-40 minutes 5
- Paradoxical agitation may occur, especially in younger children 1
- Higher doses associated with greater adverse events, particularly respiratory depression 6
Practical Considerations
When IM Route is Appropriate
IM lorazepam is reasonable when:
- IV access is unavailable or delayed
- Patient cannot take oral medication
- Rapid sedation needed but not emergent (as onset is slower than IV)
When to Choose Alternative Routes
Prefer IV route for: Status epilepticus, severe agitation requiring immediate control 1
Prefer oral/sublingual route for: Anxiety management when patient can swallow (oral tablets can be used sublingually off-label) 2
Consider subcutaneous midazolam instead when patient cannot swallow and repeated dosing anticipated, as it avoids injection site pain and has predictable absorption 2
Common Pitfalls to Avoid
- Do not use IM route as first-line for status epilepticus - IV lorazepam or IM midazolam (10 mg) are superior 7
- Do not underdose in elderly - while starting lower is appropriate, inadequate dosing leads to treatment failure
- Do not combine with multiple CNS depressants without enhanced monitoring 1
- Do not expect rapid onset - unlike IV administration, IM lorazepam takes 30-40 minutes for maximum effect 5
- Do not discharge patients within 4 hours - sedation persists and outpatient use is inappropriate 8